Business Wire

LBAi W-Gate: a New Era for Perimeter Protection, With Artificial Intelligence

Share

LBA, manufacturer of automatic bollards and automatic barriers, announces the launch of its brand-new, breakthrough development:a fast and smart gateway.

Launched at the Intertraffic exhibition, the eco-system's benchmark showcase, this smart gateway combines the advantages of the gateway and the automatic barrier to provide a compact solution that does not need to be fitted with detector cells. A complete product, which vastly improves reliability, providing security while also maintaining the smooth flow of access to public and tertiary buildings, and to industrial and logistics sites.

Manufactured in Limonest (near Lyon), this made in France product has been added to the catalogue of La Barrière Automatique.

The major innovative feature involves the dynamic LBAi DETECT patented intelligent detection system, with smart identification of pedestrians/vehicles. This smart detection system protects pedestrians and users, without having to wait for contact. It is completely safe, for pedestrians and vehicles. The on-board artificial intelligence in the camera is built into the security system.

This technology does away with the need for cells and safety edges, thus greatly reducing the risk of faults. A technology that combines speed with safety, and compliant with standard EN 13241-1. The LBA ONE-C© card links to web services, incorporating in particular the remote control and management of the gateway.

The dimensions of the LBAi W-Gate are suitable for all widths of gateway. Indeed, the width, height and design of the leaves are completely adaptable and customisable.

Bringing artificial intelligence to serve perimeter security, LBA once again demonstrates its ability to innovate. On average, LBA files 5 patents a year.

With LBAi W-Gate, we are targeting a broad range of players seeking a reliable, flexible and perimeter security solution. This product has been developed based on feedback from our customers, and with the expertise of our research and development team - my congratulations to them. We are extremely proud to unveil this gateway at Intertraffic, demonstrating as it does our dynamic sector. Security needs are constantly changing, and so barriers and gateways also have to develop in order to keep up with need,” concludes Hélène Hardouin, Chair of LBA.

Find out more: https://onlylba.com/speedgate/

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Press contact:
Agence Yucatan
Jean-Alexis Bourgier | Clothilde Mannarino
groupelba@yucatan.fr
01 53 63 27 27

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Sodali & Co Appoints Andrew Benett as Chief Executive Officer14.1.2025 10:00:00 CET | Press Release

Sodali & Co (the ‘firm’ or ‘Sodali’ and formerly Morrow Sodali), a leading global advisory firm, is pleased to announce the appointment of Andrew Benett as Chief Executive Officer, effective immediately. He will be based in New York. Andrew has a 30-year career across global advisory businesses including Global CEO and Chief Strategy Officer at Havas Creative Group, Chief Commercial Officer of Bloomberg Media and CEO and Executive Chair of Harte Hanks Inc., the NASDAQ-listed publishing company. Most recently, Andrew was a Partner at PwC working with clients to deliver organic and inorganic growth, as well as leading corporate strategy initiatives for the firm. He is an acknowledged strategist, author of three business books, and a fellow of the Aspen Institute. Andrew was appointed after a global search following Alvise Recchi stepping down as CEO last September. He joins the firm at an important moment in its development. In the last two years, Sodali has transformed at speed from a s

Bioptimus Hits $76M Funding Milestone and Prepares to Launch Groundbreaking Foundation Model for Biology14.1.2025 10:00:00 CET | Press Release

Bioptimus, the pioneering AI foundation model company, announced today that it has reached a significant funding milestone of $76 million. This total includes a $41 million cash injection, led by Cathay Innovation with participation from prominent investors, including Sofinnova Partners, Bpifrance through its Large Venture Fund, Andera Partners, Hitachi Ventures, Boom Capital Ventures, Pomifer Capital, Sunrise, and angel entrepreneurs Emmanuel Cassimatis and Thomas Wolf. The funding will accelerate Bioptimus’s mission to build the world’s first universal AI foundation model for biology, aimed at revolutionizing research and innovation across the medical, biotech, cosmetic industries, and beyond. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250114054102/en/ The company has been building momentum this year, assembling a world-class team, securing access to unique data sources, and successfully releasing its first model, H-Op

Cirium Ascend Consultancy Lands ‘Appraiser of the Year’ Title for the 10th Time14.1.2025 09:00:00 CET | Press Release

Cirium Ascend Consultancy, part of the world’s most trusted source of aviation analytics, Cirium, has once again landed Airline Economics’ prestigious title of ‘Appraiser of the Year’ at an award ceremony last night. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250113971776/en/ Cirium awarded 'Appraiser of the Year' (Photo: Business Wire) This marks the tenth win for Cirium Ascend Consultancy, demonstrating its unparalleled expertise within aviation consultancy and underlining its unwavering commitment to excellence, transparency and accuracy. The annual award was presented to Rob Morris, Global Head of Cirium Ascend Consultancy, at the Airline Economics Aviation 100 Global Leaders Awards 2025 in Dublin, Ireland, which celebrates the best companies, individuals and transactions in the aviation finance and leasing sector. 2025’s landmark win makes it the first time a single firm has won the title 10 times, recognising Ciriu

Almirall at the JPMorgan Conference - Entering a New Era of Sustained Growth14.1.2025 07:00:00 CET | Press Release

Almirall, a global pharmaceutical company dedicated to medical dermatology, is participating in the 2025 JPMorgan HealthCare Conference to provide an update on its business strategy and outlook. The company’s CEO and president Carlos Gallardo will highlight a new era for its business starting in 2025 – forecasting sustained double-digit growth of net sales (CAGR 2023-2030) and a substantial margin expansion, driven by Almirall’s focus on medical dermatology, commercial excellence, and its continued investment in R&D to innovate and advance science. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250113044812/en/ Almirall HQ in Barcelona (Photo: Business Wire) Almirall combines the strengthening of its growth drivers, particularly the biologics products, with the continued growth of its broad portfolio of medical dermatology solutions, including Klisyri®, Wynzora®, and Seysara®. Almirall’s commercial excellence has been demons

Galderma Premieres Positive Interim Results Demonstrating the Efficacy of Its Injectable Aesthetics Portfolio in Addressing Facial Volume Loss as a Result of Medication-driven Weight Loss14.1.2025 07:00:00 CET | Press Release

Galderma (SWX:GALD) announces positive first results from a trial designed to explore the benefits of Restylane® Lyft™ or Contour™ in combination with Sculptra® in patients with medication-driven weight loss with associated facial volume loss.1 Initial three-month interim data from this first-of-its-kind trial suggest that this treatment combination effectively improved facial aesthetic appearance with high patient satisfaction.1 The results will be presented later today at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, California. Rates of medication-driven weight loss have increased rapidly in recent years and can be associated with facial alterations of variable magnitude.2-4 Patients can find that their skin is less radiant, drier or saggy, and can also observe changes in their facial structure and balance.3,4 Some even find that they appear older than their age.3,4 There are several reasons for these facial alterations including loss of fat, collagen, elastin

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye